A detailed history of Public Employees Retirement System Of Ohio transactions in Nektar Therapeutics stock. As of the latest transaction made, Public Employees Retirement System Of Ohio holds 159,064 shares of NKTR stock, worth $144,748. This represents 0.0% of its overall portfolio holdings.

Number of Shares
159,064
Previous 160,064 0.62%
Holding current value
$144,748
Previous $198,000 4.04%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$1.11 - $1.48 $1,110 - $1,480
-1,000 Reduced 0.62%
159,064 $206,000
Q2 2024

Aug 14, 2024

SELL
$0.9 - $1.83 $8,716 - $17,723
-9,685 Reduced 5.71%
160,064 $198,000
Q1 2024

May 15, 2024

SELL
$0.49 - $0.96 $51,535 - $100,968
-105,175 Reduced 38.26%
169,749 $157,000
Q4 2023

Feb 15, 2024

SELL
$0.42 - $0.57 $14,784 - $20,064
-35,200 Reduced 11.35%
274,924 $153,000
Q3 2023

Dec 19, 2023

SELL
$0.51 - $1.05 $510 - $1,050
-1,000 Reduced 0.32%
310,124 $186,000
Q3 2023

Nov 15, 2023

SELL
$0.51 - $1.05 $510 - $1,050
-1,000 Reduced 0.32%
310,124 $185,000
Q2 2023

Dec 19, 2023

BUY
$0.53 - $1.03 $65,645 - $127,575
123,860 Added 66.14%
311,124 $180,000
Q2 2023

Aug 15, 2023

BUY
$0.53 - $1.03 $65,645 - $127,575
123,860 Added 66.14%
311,124 $179,000
Q4 2022

Dec 19, 2023

SELL
$2.03 - $4.28 $249,405 - $525,840
-122,860 Reduced 39.62%
187,264 $423,000
Q4 2022

Feb 15, 2023

BUY
$2.03 - $4.28 $288,564 - $608,402
142,150 Added 315.09%
187,264 $423,000
Q2 2022

Aug 15, 2022

SELL
$3.17 - $6.17 $152,936 - $297,671
-48,245 Reduced 51.68%
45,114 $171,000
Q1 2022

May 16, 2022

SELL
$4.16 - $13.72 $12,987 - $42,833
-3,122 Reduced 3.24%
93,359 $503,000
Q4 2021

Feb 15, 2022

SELL
$10.83 - $18.41 $27,973 - $47,553
-2,583 Reduced 2.61%
96,481 $1.3 Million
Q3 2021

Nov 15, 2021

SELL
$13.07 - $18.84 $29,133 - $41,994
-2,229 Reduced 2.2%
99,064 $1.78 Million
Q2 2021

Aug 16, 2021

BUY
$16.52 - $20.4 $153,074 - $189,026
9,266 Added 10.07%
101,293 $1.74 Million
Q1 2021

May 14, 2021

BUY
$16.56 - $25.46 $80,282 - $123,430
4,848 Added 5.56%
92,027 $1.84 Million
Q4 2020

Feb 12, 2021

BUY
$15.77 - $19.03 $268,862 - $324,442
17,049 Added 24.31%
87,179 $1.48 Million
Q3 2020

Nov 16, 2020

BUY
$16.59 - $24.79 $51,943 - $77,617
3,131 Added 4.67%
70,130 $1.16 Million
Q2 2020

Aug 17, 2020

BUY
$16.86 - $23.44 $15,578 - $21,658
924 Added 1.4%
66,999 $1.55 Million
Q1 2020

May 13, 2020

BUY
$14.47 - $27.96 $129,332 - $249,906
8,938 Added 15.64%
66,075 $1.18 Million
Q4 2019

Feb 14, 2020

SELL
$15.87 - $23.12 $17,869 - $26,033
-1,126 Reduced 1.93%
57,137 $1.23 Million
Q3 2019

Nov 15, 2019

BUY
$16.91 - $36.27 $1,454 - $3,119
86 Added 0.15%
58,263 $1.06 Million
Q2 2019

Aug 12, 2019

BUY
$31.0 - $36.3 $2,790 - $3,266
90 Added 0.15%
58,177 $2.07 Million
Q1 2019

May 15, 2019

BUY
$31.58 - $46.35 $3,600 - $5,283
114 Added 0.2%
58,087 $1.95 Million
Q4 2018

Feb 15, 2019

SELL
$30.43 - $56.65 $175,581 - $326,870
-5,770 Reduced 9.05%
57,973 $1.91 Million
Q3 2018

Nov 14, 2018

SELL
$46.46 - $68.49 $16,307 - $24,039
-351 Reduced 0.55%
63,743 $3.89 Million
Q2 2018

Aug 22, 2018

BUY
$46.25 - $104.45 $2.96 Million - $6.69 Million
64,094 New
64,094 $3.13 Million

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $171M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.